These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24887818)

  • 1. Full-metal jacket: A bad strategy.
    Alvarez JR; Quiroga JS; Lopez LR; Bauza AG; Cereijo JM; Taboada CR
    Asian Cardiovasc Thorac Ann; 2014 Jul; 22(6):737-8. PubMed ID: 24887818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
    Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
    EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
    Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New-Generation Drug-Eluting Stents for Left Main In-Stent Restenosis: The DELTA-2 Registry.
    Giustino G; Tanaka A; Erglis A; Morice MC; Van Mieghem NM; Meliga E; D'Ascenzo F; Stefanini GG; Capodanno D; Chieffo A;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2438-2440. PubMed ID: 30522680
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.
    Zbinden R; von Felten S; Wein B; Tueller D; Kurz DJ; Reho I; Galatius S; Alber H; Conen D; Pfisterer M; Kaiser C; Eberli FR
    Cardiovasc Ther; 2017 Feb; 35(1):19-25. PubMed ID: 27662632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe in-stent restenosis missed by coronary CT angiography and accurately detected with FFR
    Andreini D; Mushtaq S; Pontone G; Rogers C; Pepi M; Bartorelli AL
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):119-120. PubMed ID: 27581392
    [No Abstract]   [Full Text] [Related]  

  • 7. Stent failure due to simultaneous aggressive neoatherosclerosis of first- and current-generation drug-eluting stents.
    Komukai K; Bernelli C; Sirbu V; Guagliumi G
    EuroIntervention; 2015 Nov; 11(7):e1-2. PubMed ID: 26603864
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry.
    Kutcher MA; Brennan JM; Rao SV; Dai D; Anstrom KJ; Mustafa N; Sedrakyan A; Booth ME; Douglas PS; Messenger JC
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):171-81. PubMed ID: 23907981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of routine follow-up coronary angiography after second- or third-generation drug-eluting stent insertion in clinically stable patients.
    Choi S; Mun HS; Kang MK; Cho JR; Han SW; Lee N
    Korean J Intern Med; 2015 Jan; 30(1):49-55. PubMed ID: 25589835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.
    Obata JE; Nakamura T; Kitta Y; Saito Y; Sano K; Fujioka D; Kawabata K; Kugiyama K
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):E777-87. PubMed ID: 23378231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous kissing stents to treat unprotected left main stem coronary artery bifurcation disease; stent expansion, vessel injury, hemodynamics, tissue healing, restenosis, and repeat revascularization.
    Morris PD; Iqbal J; Chiastra C; Wu W; Migliavacca F; Gunn JP
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):E381-E392. PubMed ID: 29693768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-ST-segment elevation myocardial infarction related to vulnerable neoatheroma in bare-metal stents 2 years after percutaneous coronary intervention of a coronary saphenous vein graft.
    Roleder T; Wańha W; Smolka G; Ochała A; Wojakowski W
    JACC Cardiovasc Interv; 2014 Aug; 7(8):e95-6. PubMed ID: 25086848
    [No Abstract]   [Full Text] [Related]  

  • 15. Complex, diffuse in-stent atherosclerosis over a decade following bare metal stenting.
    Lau JK; Alcock RF; Brieger D; Lowe HC
    Coron Artery Dis; 2015 Aug; 26 Suppl 1():e69-70. PubMed ID: 26247273
    [No Abstract]   [Full Text] [Related]  

  • 16. In-stent restenosis because of nickel hypersensitivity: a bioresorbable solution?
    Granata F; Moscarella E; Varricchio A
    Coron Artery Dis; 2015 Aug; 26(5):461-2. PubMed ID: 25816019
    [No Abstract]   [Full Text] [Related]  

  • 17. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
    Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R;
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions.
    Coroleu SF; De Vita M; Burzotta F; Trani C; Porto I; Niccoli G; Leone AM; Tommasino A; Talarico GP; Schiavoni G; Crea F
    EuroIntervention; 2012 Oct; 8(6):701-7. PubMed ID: 23086788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.